Unexpectedly large CV benefit with icosapent ethyl in statin-treated patients at high CV risk - PACE-CME

Unexpectedly large CV benefit with icosapent ethyl in statintreated patients at high CV risk

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Physical activity: every step counts, for everybody
Physical activity: every step counts, for everybody
AHA 2018
Physical activity: every step counts, for everybody
- Admiral Brett Giroir, MD
Practice-changing results on in-hospital treatment of acute decompensated HF
Practice-changing results on in-hospital treatment of acute decompensated HF
AHA 2018
Practice-changing results on in-hospital treatment of acute decompensated HF
- Larry Allen, MD
Vitamin D and omega-3 supplements did not meet primary cancer and CV endpoints in primary prevention cohort
Vitamin D and omega-3 supplements did not meet primary cancer and CV endpoints in primary prevention cohort
AHA 2018
Vitamin D and omega-3 supplements did not meet primary cancer and CV endpoints in primary prevention cohort
- JoAnn Manson, MD
Not all fish oils are created equal: different compounds have different effects
Not all fish oils are created equal: different compounds have different effects
AHA 2018
Not all fish oils are created equal: different compounds have different effects
- Deepak Bhatt, MD